These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 1675216)
1. Alpha 1-adrenoceptor blockade and/or 5-HT1A agonism during treadmill exercise in dogs. Grohs JG; Fischer G; Huber S; Raberger G J Auton Pharmacol; 1991 Apr; 11(2):101-7. PubMed ID: 1675216 [TBL] [Abstract][Full Text] [Related]
2. Influence of alpha 1-adrenoceptor blockade and/or 5-HT1A agonism on blood pressure and heart rate at rest and during exercise in hypertensive dogs. Grohs JG; Huber S; Fischer G; Raberger G J Auton Pharmacol; 1992 Jun; 12(3):157-64. PubMed ID: 1352778 [TBL] [Abstract][Full Text] [Related]
3. Differential cardiovascular effects of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), flesinoxan, 5-methyl-urapidil and MDL 75,608A in conscious spontaneously hypertensive rats. Buisson-Defferier S; Hibert M; van den Buuse M Fundam Clin Pharmacol; 1993; 7(9):499-511. PubMed ID: 7906241 [TBL] [Abstract][Full Text] [Related]
4. Involvement of brain 5-HT1A receptors in the hypotensive response to urapidil. Kolassa N; Beller KD; Sanders KH Am J Cardiol; 1989 Aug; 64(7):7D-10D. PubMed ID: 2569265 [TBL] [Abstract][Full Text] [Related]
5. Evidence that different regional sympathetic outflows vary in their sensitivity to the sympathoinhibitory actions of putative 5-HT1A and alpha 2-adrenoceptor agonists in anaesthetized cats. Ramage AG; Wilkinson SJ Br J Pharmacol; 1989 Dec; 98(4):1157-64. PubMed ID: 2575414 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat. Dreteler GH; Wouters W; Saxena PR Eur J Pharmacol; 1990 May; 180(2-3):339-49. PubMed ID: 2142096 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects of the 5-HT1A receptor ligand, MDL 73005EF, in conscious spontaneously hypertensive rats. Buisson-Defferier S; Van den Buuse M Eur J Pharmacol; 1992 Nov; 223(2-3):133-41. PubMed ID: 1362161 [TBL] [Abstract][Full Text] [Related]
8. 5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm. Millan MJ; Rivet JM; Gobert A; Canton H; Veiga S; Bervoets K J Pharmacol Exp Ther; 1994 Apr; 269(1):121-31. PubMed ID: 7909555 [TBL] [Abstract][Full Text] [Related]
9. Involvement of 5-HT1A receptors in blood pressure reduction by 8-OH-DPAT and urapidil in cats. Sanders KH; Beller KD; Kolassa N J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S86-93. PubMed ID: 1702492 [TBL] [Abstract][Full Text] [Related]
10. Systemic and regional hemodynamic effects of the putative 5-HT1A receptor agonist flesinoxan in the cat. Dreteler GH; Wouters W; Saxena PR J Cardiovasc Pharmacol; 1989 Nov; 14(5):770-6. PubMed ID: 2481192 [TBL] [Abstract][Full Text] [Related]
11. Central 5-HT1A receptors and the mechanism of the central hypotensive effect of (+)8-OH-DPAT, DP-5-CT, R28935, and urapidil. Doods HN; Boddeke HW; Kalkman HO; Hoyer D; Mathy MJ; van Zwieten PA J Cardiovasc Pharmacol; 1988 Apr; 11(4):432-7. PubMed ID: 2453746 [TBL] [Abstract][Full Text] [Related]
12. Interaction of urapidil with brain serotonin-1A receptors increases the blood pressure reduction due to peripheral alpha-adrenoceptor inhibition. Sanders KH; Beller KD; Bischler P; Kolassa N J Hypertens Suppl; 1988 Dec; 6(2):S65-8. PubMed ID: 2906703 [TBL] [Abstract][Full Text] [Related]
13. Urapidil analogues are potent ligands of the 5-HT1A receptor. Gross G; Schüttler K; Xin X; Hanft G J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S8-16. PubMed ID: 1702491 [TBL] [Abstract][Full Text] [Related]
14. Contractile effects of 8-hydroxy-2-(di-n-propylamino)tetralin and flesinoxan in human isolated basilar artery. Parsons AA; Motevalian M; Whalley ET Eur J Pharmacol; 1991 Sep; 202(1):17-23. PubMed ID: 1664803 [TBL] [Abstract][Full Text] [Related]
15. Systemic and regional hemodynamic effects of the 5-hydroxytryptamine1A receptor agonists flesinoxan and 8-hydroxy-2(di-N-propylamino)tetralin in the conscious rat. Dreteler GH; Wouters W; Toorop GP; Jansen JA; Saxena PR J Cardiovasc Pharmacol; 1991 Mar; 17(3):488-93. PubMed ID: 1711612 [TBL] [Abstract][Full Text] [Related]
17. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors. Clarke RW; Ogilvie J; Houghton AK Br J Pharmacol; 1997 Oct; 122(4):631-8. PubMed ID: 9375958 [TBL] [Abstract][Full Text] [Related]
18. Experimental studies on the neurocardiovascular effects of urapidil. Gillis RA; Kellar KJ; Quest JA; Namath IJ; Martino-Barrows A; Hill K; Gatti PJ; Dretchen K Drugs; 1988; 35 Suppl 6():20-33. PubMed ID: 2900129 [TBL] [Abstract][Full Text] [Related]
19. Influence of urapidil and 8-OH-DPAT on brain 5-HT turnover and blood pressure in rats. Valenta B; Kotai E; Weisz E; Singer EA J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S68-74. PubMed ID: 1702489 [TBL] [Abstract][Full Text] [Related]
20. Hypotensive effects of 8-hydroxy-2-(di-n-propylamino)tetralin and 5-methylurapidil following stereotaxic microinjection into the ventral medulla of the rat. Valenta B; Singer EA Br J Pharmacol; 1990 Apr; 99(4):713-6. PubMed ID: 1972893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]